Welcome to Scholar Publishing Group
Immunotherapy for Lung Cancer: Frontiers and Advances | Scholar Publishing Group

Immunotherapy for Lung Cancer: Frontiers and Advances

Published Date: February 29th 2024

Page Length: 399

Language: English

ISBN: 978-1-80053-777-4

Price: £40.00


Lung cancer, as one of the most common malignant tumors worldwide, poses a huge threat to human life and health. With the continuous development of medical science, especially breakthroughs in the field of immunotherapy, the treatment methods of lung cancer are undergoing profound changes. This book “Immunotherapy for Lung Cancer: Frontiers and Advances” aims to comprehensively review and summarize the cutting-edge knowledge and technological progress in the field of lung cancer immunotherapy, providing valuable references for researchers, medical workers, and all those concerned with lung cancer prevention and treatment. 

In the chapter on understanding lung cancer in modern medicine, we will delve into the causes and development process of lung cancer, as well as its relationship with lifestyle and environmental factors. We will analyze the complexity of lung cancer from multiple perspectives to help readers better understand this disease. The immunological foundation chapter of lung cancer will focus on the relationship between lung cancer and the immune system, revealing how tumors evade immune system attacks through various mechanisms. This section will lay a solid foundation for the exploration of subsequent immunotherapy strategies. The chapter on the treatment and prevention of lung cancer will provide a comprehensive overview of traditional treatment methods for lung cancer, such as surgery, chemotherapy, and radiation therapy. It will also focus on introducing the latest applications and prevention strategies of immunotherapy in lung cancer. In the chapter on the basic principles of immunotherapy for lung cancer, we will delve into the working mechanisms of the immune system and how tumors can use various mechanisms to evade immune attacks. In addition, a detailed introduction will be given to the new immune checkpoint therapies currently under research. In the chapter on immunotherapy technology and clinical analysis for lung cancer, a detailed analysis of current immunotherapy methods will be conducted, and their application effects in clinical practice will be explored. In addition, in-depth exploration will be conducted on the immunotherapy research of non-small cell lung cancer (NSCLC) that can be operated on. The strategy chapter of lung cancer immunotherapy will focus on how to improve the efficacy of lung cancer immunotherapy through combination therapy. We will explore the potential roles of anti angiogenic drugs, tumor cell vaccines, and integrated traditional Chinese and Western medicine in immunotherapy. Finally, in the chapter on the challenges and prospects of immunotherapy for lung cancer, an in-depth analysis will be conducted on the current challenges faced by immunotherapy for lung cancer, and forward-looking thinking will be given on its future development direction. At the same time, we will also pay attention to the development trends in the field of precision therapy for lung cancer, in order to provide valuable references for future clinical practice.

Tabale of Contents

Download Full Text